Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;18(3):18.
doi: 10.1007/s11912-016-0504-2.

New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer

Affiliations
Review

New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer

Romain Cohen et al. Curr Oncol Rep. 2016 Mar.

Abstract

Recently, colorectal cancer (CRC) subtyping consortium identified four consensus molecular subtypes (CMS1-4). CMS1 is enriched for deficient mismatch repair (dMMR) and BRAF (V600E) tumors. Intriguingly, this subtype has better relapse-free survival but worse overall survival after relapse compared with the other subtypes. Growing evidence is accumulating on the benefit of specific therapeutic strategies such as immune checkpoint inhibition therapy in dMMR tumors and mitogen-activated protein kinase (MAPK) pathway targeted therapy in tumors harboring BRAF (V600E) mutation. After reviewing dMMR prognostic value, immune checkpoints as major targets for dMMR carcinomas will be highlighted. Following, BRAF (V600E) prognostic impact will be reviewed and therapeutic strategies with the combination of cytotoxic agents and especially the combinations of BRAF and MAPK inhibitors will be discussed.

Keywords: BRAF mutation; Immune checkpoint; Microsatellite instability; PD-1; PD-L1.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 2005 Dec 22;353(25):2654-66 - PubMed
    1. N Engl J Med. 2015 Jan 1;372(1):30-9 - PubMed
    1. Gastroenterology. 2015 Oct;149(4):1017-29.e3 - PubMed
    1. Am J Pathol. 1999 Jun;154(6):1805-13 - PubMed
    1. Clin Cancer Res. 2008 Jun 1;14(11):3408-15 - PubMed

MeSH terms

LinkOut - more resources